LONDON, UNITED KINGDOM- A report released today by the UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) shows that Pfizer’s pill reduces hospitalization and death risk.
First to receive the pill, named Paxlovid, in the UK will be those most at risk of becoming seriously ill from coronavirus.
According to The Independent Report, the medicine comes in the form of a pill, and is a combination of the two active ingredients PF-07321332 and ritonavir.
The drug protects those with Coronavirus by suppressing the protease that causes the virus to replicate.
Taking the pill will therefore lower the levels of Coronavirus in a person’s body, which will make it easier for their body to fight off the infection.
The ingredient ritonavir aids the effectiveness of the other ingredient, PF-07321332, by slowing the process of it being broken down.
It has been reported that Paxlovid is 89 per cent effective when taken as soon as symptoms develop, according to Pfizer.
Trials were even prematurely stopped due to the success of the early results, according to the US Company.
According to Pfizer’s chairman and CEO, Albert Bourla, the pill is ‘potentially life-saving, reduces Covid-19 infections, and eliminates up to nine out of ten hospitalizations’.
It is said that three pills should be taken two times a day for five days.
In his remarks to the MHRA prior to the approval, Health and Social Care Secretary Sajid Javid said the drug was ‘incredible’ and could be ‘a significant addition to our arsenal of treatments that combat the virus’.
The Department of Health reports that more than 2.75 million Paxlovid courses have been secured for NHS patients and that “plans for deployment will be set out soon”.